<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Achondroplasia</z:e>, the most common cause of <z:mp ids='MP_0002657'>chondrodysplasia</z:mp> in man, is characterized by <z:hpo ids='HP_0008873'>short-limbed dwarfism</z:hpo>, <z:hpo ids='HP_0000256'>macrocephaly</z:hpo>, and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> of metaphyses of the tubular bones </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, mutations in the gene encoding fibroblast growth factor receptor-3 (FGFR-3) have been found in patients with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> mutations so far reported had occurred at codon 380, resulting in the substitution of an arginine for a glycine in the transmembrane domain of the predicted protein </plain></SENT>
<SENT sid="3" pm="."><plain>We have examined the transmembrane domain of the FGFR-3 gene in seven Japanese patients with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Of the six cases that were <z:hpo ids='HP_0003745'>sporadic</z:hpo>, <z:hpo ids='HP_0000001'>all</z:hpo> carried a mutation in codon 380; the single familial case bore a novel mutation of a G-to-T transition at codon 375, which resulted in substitution of a cysteine for a glycine </plain></SENT>
</text></document>